• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overactive bladder.膀胱过度活动症
F1000Res. 2015 Dec 7;4. doi: 10.12688/f1000research.7131.1. eCollection 2015.
2
Urodynamic findings in women with refractory overactive bladder symptoms.难治性膀胱过度活动症症状女性的尿动力学检查结果
Int J Urol. 2016 Jan;23(1):75-9. doi: 10.1111/iju.12954. Epub 2015 Sep 28.
3
Overactive bladder.膀胱过度活动症。
Maturitas. 2010 Jul;66(3):257-62. doi: 10.1016/j.maturitas.2010.03.010. Epub 2010 Apr 15.
4
Correlation of the Overactive Bladder Symptom Score, and the Voiding Diary and Urodynamic Parameters in Patients with Overactive Bladder Syndrome.膀胱过度活动症患者的膀胱过度活动症症状评分、排尿日记与尿动力学参数的相关性
Low Urin Tract Symptoms. 2014 Sep;6(3):180-4. doi: 10.1111/luts.12035. Epub 2013 Oct 9.
5
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.对100例抗胆碱能药物难治性特发性膀胱过度活动症患者进行肉毒杆菌A毒素膀胱逼尿肌注射治疗的经验。
J Urol. 2006 Jul;176(1):177-85. doi: 10.1016/S0022-5347(06)00590-8.
6
The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.无张力阴道吊带对压力性尿失禁女性膀胱过度活动症症状的影响:逼尿肌过度活动的意义
J Urol. 2008 Jan;179(1):214-9. doi: 10.1016/j.juro.2007.08.151. Epub 2007 Nov 14.
7
Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.经胫神经刺激治疗对药物治疗无反应的膀胱过度活动症。
J Obstet Gynaecol. 2010 Feb;30(2):111-4. doi: 10.3109/01443610903428922.
8
Management and rehabilitation of neurologic patients with lower urinary tract dysfunction.下尿路功能障碍神经科患者的管理与康复
Handb Clin Neurol. 2015;130:451-68. doi: 10.1016/B978-0-444-63247-0.00026-2.
9
Overactive bladder syndrome - management and treatment options.膀胱过度活动症——管理与治疗选择
Aust Fam Physician. 2012 Nov;41(11):878-83.
10
The medical management of urinary incontinence.尿失禁的医学管理。
Auton Neurosci. 2010 Jan 15;152(1-2):4-10. doi: 10.1016/j.autneu.2009.09.022. Epub 2009 Nov 8.

引用本文的文献

1
Cell-free biodegradable electroactive scaffold for urinary bladder tissue regeneration.用于膀胱组织再生的无细胞可生物降解电活性支架
Nat Commun. 2025 Jan 2;16(1):11. doi: 10.1038/s41467-024-55401-9.
2
Detrusor underactivity is associated with metabolic syndrome in aged primates.逼尿肌活动低下与老年灵长类动物的代谢综合征有关。
Sci Rep. 2023 Apr 25;13(1):6716. doi: 10.1038/s41598-023-33112-3.
3
Virulence Mechanisms of Common Uropathogens and Their Intracellular Localisation within Urothelial Cells.常见尿路病原体的毒力机制及其在尿路上皮细胞内的定位
Pathogens. 2022 Aug 17;11(8):926. doi: 10.3390/pathogens11080926.
4
Antimuscarinic Use in Men Treated With Bladder Outlet Obstruction Medication Therapy.抗毒蕈碱药物在接受膀胱出口梗阻药物治疗男性中的应用。
Urology. 2018 Dec;122:76-82. doi: 10.1016/j.urology.2018.08.039. Epub 2018 Sep 8.
5
Mirabegron: A Review in Overactive Bladder Syndrome.米拉贝隆:治疗膀胱过度活动症的研究进展。
Drugs. 2018 Jun;78(8):833-844. doi: 10.1007/s40265-018-0924-4.
6
The attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey.土耳其泌尿外科医生和妇科医生对膀胱过度活动症及其治疗的态度:一项问卷调查
Turk J Urol. 2017 Mar;43(1):68-74. doi: 10.5152/tud.2016.93467. Epub 2017 Jan 27.

本文引用的文献

1
Patient preferences for treating refractory overactive bladder in the UK.英国患者对治疗难治性膀胱过度活动症的偏好。
Int Urol Nephrol. 2015 Oct;47(10):1619-27. doi: 10.1007/s11255-015-1100-3. Epub 2015 Sep 7.
2
Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.膀胱过度活动症中骶神经调节的经济学评估:加拿大视角
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):242-7. doi: 10.5489/cuaj.2711.
3
Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.经皮胫神经刺激与托特罗定治疗女性膀胱过度活动症的随机对照试验。
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:51-6. doi: 10.1016/j.ejogrb.2015.05.014. Epub 2015 Jun 3.
4
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.一项前瞻性多中心研究的结果,该研究评估了膀胱过度活动症患者在十二个月时骶神经调节的生活质量、安全性和疗效。
Neurourol Urodyn. 2016 Feb;35(2):246-51. doi: 10.1002/nau.22707. Epub 2014 Dec 24.
5
Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.索利那新与坦索罗辛口服控释系统单片复方制剂治疗男性储尿和排尿下尿路症状的长期安全性和疗效:NEPTUNE 研究和 NEPTUNE II 开放性扩展研究结果。
Eur Urol. 2015 Feb;67(2):262-70. doi: 10.1016/j.eururo.2014.07.013. Epub 2014 Jul 25.
6
You are what you eat: the impact of diet on overactive bladder and lower urinary tract symptoms.吃什么,你就是什么:饮食对膀胱过度活动症和下尿路症状的影响。
Maturitas. 2014 Sep;79(1):8-13. doi: 10.1016/j.maturitas.2014.06.009. Epub 2014 Jun 17.
7
Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013.我们是否需要膀胱过度活动症综合征的新定义?国际尿控学会-2013研讨会。
Neurourol Urodyn. 2014 Jun;33(5):622-4. doi: 10.1002/nau.22609. Epub 2014 May 16.
8
Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men.在健康中年至老年男性中,在已确立的坦索罗辛或米拉贝隆治疗基础上加用米拉贝隆或坦索罗辛时,未出现临床相关的心血管相互作用。
Int J Clin Pharmacol Ther. 2014 Aug;52(8):693-701. doi: 10.5414/CP201979.
9
Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.尿急和频度总评分作为评估膀胱过度活动症和储尿期下尿路症状尿急和频度的指标。
BJU Int. 2014 May;113(5):696-703. doi: 10.1111/bju.12555. Epub 2014 Feb 20.
10
Developing and validating the International Consultation on Incontinence Questionnaire bladder diary.研制和验证国际尿失禁咨询委员会尿失禁问卷膀胱日记。
Eur Urol. 2014 Aug;66(2):294-300. doi: 10.1016/j.eururo.2014.02.057. Epub 2014 Mar 11.

膀胱过度活动症

Overactive bladder.

作者信息

Wallace Karen M, Drake Marcus J

机构信息

Bristol Urological Institute, Southmead Hospital, Bristol, UK.

出版信息

F1000Res. 2015 Dec 7;4. doi: 10.12688/f1000research.7131.1. eCollection 2015.

DOI:10.12688/f1000research.7131.1
PMID:26918151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4754030/
Abstract

Overactive bladder syndrome is highly prevalent, and increasingly so with aging. It is characterized by the presence of urinary urgency, and can be associated with incontinence, increased voiding frequency, and nocturia. Assessment needs to exclude serious medical disorders that might present with similar symptoms, and a bladder diary is an invaluable part of understanding the presentation. Initial management is conservative, comprising education, bladder training, and advice on fluid intake. Drug therapy options include antimuscarinic medications and beta-3 adrenergic receptor agonists. Persistent overactive bladder syndrome, despite initial therapy, requires a review of the patient's understanding of conservative management and compliance, and adjustment of medications. For refractory cases, specialist review and urodynamic testing should be considered; this may identify detrusor overactivity or increased filling sensation, and needs to exclude additional factors, such as stress incontinence and voiding dysfunction. Botulinum neurotoxin-A bladder injections can be used in severe overactivity, provided the patient is able and willing to do intermittent self-catheterisation, which is necessary in about 5% of treated patients. Sacral nerve stimulation and tibial nerve stimulation are other approaches. Major reconstructive surgery, such as augmentation cystoplasty, is rarely undertaken in modern practice but remains a possibility in extreme cases.

摘要

膀胱过度活动症非常普遍,且随着年龄增长愈发常见。其特征为尿急,可能伴有尿失禁、排尿频率增加及夜尿症。评估需排除可能出现类似症状的严重医学病症,膀胱日记是了解病情的重要部分。初始治疗为保守治疗,包括教育、膀胱训练及饮水建议。药物治疗选择包括抗毒蕈碱药物和β-3肾上腺素能受体激动剂。尽管进行了初始治疗,但持续性膀胱过度活动症仍需复查患者对保守治疗的理解及依从性,并调整药物。对于难治性病例,应考虑专科复查及尿动力学检查;这可能发现逼尿肌过度活动或充盈感增强,且需排除其他因素,如压力性尿失禁和排尿功能障碍。肉毒杆菌神经毒素A膀胱注射可用于严重的过度活动症,但患者必须能够且愿意进行间歇性自我导尿,约5%的接受治疗患者需要这样做。骶神经刺激和胫神经刺激是其他治疗方法。现代医疗实践中很少进行诸如膀胱扩大术等大型重建手术,但在极端情况下仍有可能实施。